Save the Date... Read MoreInternal Medicine
Division of Hematology & Hematologic Malignancies
The scientific focus of our division is the study of blood and bone marrow in health and disease. Our physicians treat patients with blood cancer, such as leukemias and lymphomas; clotting disorders, such as hemophilia; and diseases of iron metabolism, such as hemochromatosis. Starting with Maxwell Wintrobe, one of the founding fathers of Hematology and the University of Utah Medical School, our division can look back at a long-standing tradition of excellence in research, clinical care and teaching.
Dee-Cartwright Endowed Research Fund
The Division of Hematology and Hematologic Malignancies in the Department of Internal Medicine is pleased to announce the establishment of an endowed research fund in honor of Dr. George E. Cartwright, the first chief of the Division Hematology and Hematologic Malignancies and the second chair of the Department of Internal Medicine. The Division is grateful to Candace Cartwright Dee, Dr. Cartwright’s daughter, and her husband Tim Dee, for their generous gift to establish this fund that recognizes Dr. Cartwright’s legacy as a renowned investigator in hematology. During his career, Dr. Cartwright’s research aided countless patients while his mentorship inspired generations of hematologists. The Dee-Cartwright Endowed Research Fund will honor his heritage by expanding the range and deepening the impact of hematology research at University of Utah. Consistent with Dr. Cartwright’s holistic view and the universal role of hematology within medicine, the fund will support research efforts related to both benign and malignant and hematologic conditions, providing critical support for early investigators, and seed money to foster the development of research projects until they garner federal support.
Congratulations to Dr. Ahmad Halwani.... Read MoreInternal Medicine
The Utah Center for Bleeding & Clotting Disorders (UCBCD) is committed to providing a comprehensive medical home with state-of-the-art treatment, family-centered education and ground-breaking research to children, adolescents, and adults with hemophilia and related bleeding and clotting disorders across the state.... Read MoreInternal Medicine
Congratulations to Dr. Vedran Radojcic.... Read MoreInternal Medicine
CIHD Social Media Announcement... Read MoreInternal Medicine
Researchers at Huntsman Cancer Institute at the University of Utah discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells.... Read MoreInternal Medicine